Vancomycin and ototoxicity

No studies demonstrate conclusive evidence of ototoxicity with vancomycin administration alone and in therapeutic doses. No recommendations have been made regarding its use; however, the authors suggest caution with coadministration of vancomycin and other ototoxic agents, and documentation of vancomycin serum levels.

Moderate ototoxicity (40 decibels) in this case improved after 15 days following vancomycin administration.8 Thus, vancomycin-associated

Effect of N - acetylcysteine in the prevention of ototoxicity caused by vancomycin in the treatment of peritonitis in patients undergoing peritoneal dialysis.

vancomycin in terms of the volume of distribution and the rate of drug clearance from plasma.1. The risk of ototoxicity and nephrotoxicity from vancomycin

Ototoxicity is a rare complication associated with vancomycin monotherapy. It is common in patients receiving excessive vancomycin doses, concurrent ototoxic medications (e.g, aminoglycosides, loop diuretics, antineoplastic agents), and those with underlying hearing loss conditions.

2024 Jan; 92(1): . Page 28. Vancomycin Ototoxicity. Vancomycin is a glycopeptide antibiotic used for. MRSA, strep endocarditis, and Clostridium

Vancomycin hydrochloride should be used with care in patients with renal insufficiency because of its ototoxicity and nephrotoxicity. The dose

ototoxicity, clarithromycin ototoxicity, macrolide ototoxicity, vancomycin ototoxicity and chloramphenicol ototoxicity. CAPREOMYCIN OTOTOXICITY.

As of 2024, it appeared that in all cases of permanent SNHL attributed to vancomycin ototoxicity the patient received an aminoglycoside antibiotic just before, during, or shortly after vancomycin. In those cases, vancomycin may have interacted with the aminoglycoside to cause ototoxicity, or that the hearing loss was caused by an aminoglycoside